HAB Pharmaceuticals
Diabetes Care1X15 Tablet
Prescription required
This medicine is dispensed only against a valid prescription from a registered medical practitioner. You’ll be asked to upload it at checkout, and a pharmacist reviews it before dispatch.
Prescription policyYou save ₹160.00 · Inclusive of all taxes
GLIPVAS 50 tablet — VILDAGLIPTIN 50 mg by HAB Pharmaceuticals. Tablet form, packed in strip. Category: Diabetes Care. Country of origin: India.
Available on order. The seller arranges supply before dispatch.
Product: GLIPVAS 50. Active ingredient: VILDAGLIPTIN 50 mg per tablet. Form: Tablet. Packing: Strip. Brand: HAB Pharmaceuticals. Main category: Medicine — Diabetes Care. Country of origin: India. This entry records the manufacturer, composition and packaging details supplied by the vendor. For therapeutic information, follow the product leaflet and the instructions of your healthcare provider.
GLIPVAS 50 is a medicine product supplied by HAB Pharmaceuticals containing VILDAGLIPTIN 50 mg per tablet. It is presented as tablets in strip packing and is listed under the Diabetes Care category. This product page provides factual product details only. For information on clinical use, dosing, contraindications, side effects, mechanism of action or interactions, consult the printed product label, your prescribing doctor, or a pharmacist. Do not use this page as a substitute for professional medical advice.
The vendor-provided facts do not include indications or approved medical uses. Although the product is listed under the Diabetes Care category and contains VILDAGLIPTIN 50 mg, this page does not specify how it should be used therapeutically. For authorised indications, treatment goals and whether this medicine is suitable for you, refer to the official product leaflet, or ask your prescribing doctor or pharmacist for clinical guidance.
The vendor information classifies GLIPVAS 50 in the Diabetes Care category and lists its composition as VILDAGLIPTIN 50 mg. This product listing does not provide specific clinical benefit claims or treatment indications. To understand the intended therapeutic benefits, expected outcomes and whether this medicine is appropriate for you, consult the printed product leaflet, your prescribing doctor or a qualified pharmacist for personalised clinical guidance.
VILDAGLIPTIN 50 mg (per tablet). Ingredient list as supplied by the vendor: VILDAGLIPTIN 50 mg.
Follow the directions provided on the product label or those given by your prescribing doctor or pharmacist. The vendor-supplied facts identify the active ingredient and strength but do not include specific dosing schedules or administration instructions. Do not change dose, frequency, or stop treatment without consulting your prescriber. If the product label or prescription is unclear, contact the dispensing pharmacist or your doctor for clarification before taking the medicine.
Only use GLIPVAS 50 under the supervision of a healthcare professional and according to the product label or prescription. Inform your doctor or pharmacist about all medicines, supplements and medical conditions before starting this product. Do not share prescription medicines with others. If you are pregnant, planning pregnancy, breastfeeding, have liver or kidney conditions, or any other health concerns, consult your prescriber for personalised advice. For any uncertainty about safety, follow up with the prescribing physician or pharmacist. The supplier-provided facts do not include a side effect profile. For information about possible adverse effects, frequency, severity and what to do if you experience them, refer to the product leaflet that comes with the pack or contact your prescribing healthcare professional or pharmacist. If you experience any unexpected or severe symptoms after taking the medication, seek medical attention promptly. Do not rely solely on this product summary for safety details.
Vendor facts do not include specific warnings or contraindications. General precautions include: follow the prescription and product leaflet; inform your healthcare provider about allergies, other medications and health conditions; do not share the medicine; and seek medical advice if you experience concerning symptoms. For authoritative warnings and contraindications applicable to this product, refer to the printed leaflet or consult your prescribing doctor or pharmacist. No interaction information is supplied by the vendor with the provided product facts. To avoid potential interactions, inform your prescriber and pharmacist about all prescription medicines, over-the-counter drugs, herbal supplements and vitamins you are taking. For a professional assessment of interaction risk specific to VILDAGLIPTIN 50 mg, consult the product leaflet, your prescribing doctor or pharmacist before starting GLIPVAS 50.
The vendor facts do not specify storage conditions or shelf life. Store medicines in their original strip packaging and keep them out of reach of children. For exact storage temperature, humidity recommendations and expiry information, check the product label or leaflet. If you are unsure how to store this medicine, ask your pharmacist or consult the manufacturer’s instructions provided with the pack.
Returns and cancellations follow our return policy. Availability and prescription checks are confirmed at checkout.
GLIPVAS 50 is listed as a medicine. Use it only as directed by a registered medical practitioner.
Yes. It is dispensed only against a valid prescription from a registered medical practitioner, which you upload at checkout.
The vendor facts do not specify storage conditions or shelf life. Store medicines in their original strip packaging and keep them out of reach of children. For exact storage temperature, humidity recommendations and expiry information, check the product label or leaflet. If you are unsure how to store this medicine, ask your pharmacist or consult the manufacturer’s instructions provided with the pack.